Customize your JAMA Network experience by selecting one or more topics from the list below.
Residents and staff of long-term care facilities (LTCFs) have been prioritized by the Advisory Committee on Immunization Practices for vaccination in the initial COVID-19 vaccine allocation phase in the US.1 Residents and staff of LTCFs, who live and work in congregate settings, are at increased risk for infection with SARS-CoV-2,2 and residents, given their advanced age and/or underlying chronic medical conditions, are at increased risk for severe outcomes.3
To facilitate vaccination of LTCF residents and staff, the Centers for Disease Control and Prevention (CDC) launched the Pharmacy Partnership for Long-Term Care Program4 in December 2020. This public-private partnership between CDC, CVS Pharmacy, Managed Health Care Associates Inc, and Walgreens provides on-site COVID-19 vaccination of residents and staff members at enrolled LTCFs, including skilled nursing facilities (SNFs), assisted living facilities, and other LTCFs across 54 jurisdictions (49 states, 4 cities, and 1 territory). Pharmacy partners provide comprehensive management of the vaccination process to include scheduling, cold chain management, patient counseling, and administration. This Insights describes estimated rates of early receipt of vaccine among residents and staff during the first month of the program, as recently reported in MMWR.5
Gharpure R, Patel A, Link-Gelles R. First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff. JAMA. 2021;325(16):1670–1671. doi:10.1001/jama.2021.2352
Create a personal account or sign in to: